Hangzhou Diagens Biotechnology Co (HKSE:02526) General and Admin. Expense: HK$32.85 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02526 Hangzhou Diagens Biotechnology Co Ltd HKSE:02526
8 GF Score
Price HK$370.00
! 2 Warning Signs
View Full Analysis

What is Hangzhou Diagens Biotechnology Co General and Admin. Expense?

Hangzhou Diagens Biotechnology Co HKSE:02526 -1.07% 8 General and Admin. Expense is HK$32.85 Mil as of Jun. 2026. GuruFocus rates HKSE:02526 with a GF Score™ of 8/100. The stock has 2 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Hangzhou Diagens Biotechnology Co's General and Admin. Expense for the three months ended in Jun. 2026 was HK$0.00 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 was HK$32.85 Mil.

Hangzhou Diagens Biotechnology Co General and Admin. Expense Related Terms

Hangzhou Diagens Biotechnology Co General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Hangzhou Diagens Biotechnology Co's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Diagens Biotechnology Co General and Admin. Expense Chart

Hangzhou Diagens Biotechnology Co Annual Data
Trend Dec23 Dec24 Dec25
General and Admin. Expense
7.36 6.69 62.67

Hangzhou Diagens Biotechnology Co Quarterly Data
Dec23 Dec24 Sep25 Dec25 Jun26
General and Admin. Expense 0.00 3.03 -3.81 36.66 0.00
HKSE:02526
8GF Score
Hangzhou Diagens Biotechnology Co Ltd HKSE:02526
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou Diagens Biotechnology Co General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$32.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of HK$32.85 Mil mean?
Hangzhou Diagens Biotechnology Co (HKSE:02526) has a General and Admin. Expense of HK$32.85 Mil as of Jun. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Hangzhou Diagens Biotechnology Co and its competitors.
Is Hangzhou Diagens Biotechnology Co's General and Admin. Expense too high?
Hangzhou Diagens Biotechnology Co's current General and Admin. Expense is HK$32.85 Mil. Overall, Hangzhou Diagens Biotechnology Co has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Diagens Biotechnology Co's General and Admin. Expense compare to ABT and SYK?
Hangzhou Diagens Biotechnology Co's General and Admin. Expense of HK$32.85 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Medical Devices & Instruments company?
A good General and Admin. Expense depends on the Medical Devices & Instruments industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Hangzhou Diagens Biotechnology Co and its competitors. Hangzhou Diagens Biotechnology Co's current General and Admin. Expense is HK$32.85 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Diagens Biotechnology Co stock overvalued right now?
Hangzhou Diagens Biotechnology Co (HKSE:02526) has a current General and Admin. Expense of HK$32.85 Mil. The current General and Admin. Expense is HK$32.85 Mil. Hangzhou Diagens Biotechnology Co's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Hangzhou Diagens Biotechnology Co (HKSE:02526), the current General and Admin. Expense is HK$32.85 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hangzhou Diagens Biotechnology Co Business Description

Address No. 609 Hongfeng Road, Room 101, Building 1, Donghu Sub-district, Linping District, Zhejiang, Hangzhou, CHN
Hangzhou Diagens Biotechnology Co Ltd and its subsidiaries are involved in the development and commercialisation of medical imaging artificial intelligence technologies and medical imaging equipment. It has self-developed a diversified portfolio, including six medical imaging software products, three commercialized medical devices, four key reagents and consumables and two technology licensing offerings. Its Core Product, AI AutoVision, is an auxiliary diagnostic software designed to undertake intelligent analysis on chromosome karyotyping. The majority of the company's revenue is derived from Technology Licensing, mainly in the Chinese mainland.
8GF Score

Get the complete analysis for HKSE:02526

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$370.00
Price